Furthermore, since the increased expression of HLA-G and TIGIT correlated with a better clinical outcome of patients, these data suggested that, at least in this cohort of patients, these two molecules are not involved in the inhibition of anti-tumor T cell response. This evidence concerns the gene HLA-G and neoplasm.